CELL THERAPEUTICS, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 10th, 2005 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
Cell Therapeutics, Inc., a corporation organized under the laws of the State of Washington (the “Company”), proposes to issue and sell to the initial purchaser (the “Initial Purchaser”) named in the Purchase Agreement, dated October 31, 2005, by and between the Initial Purchaser and the Company (the “Purchase Agreement”), its 6.75% Convertible Senior Notes due 2010 (the “Securities”) and warrants to purchase 350,000 shares of its Common Stock (the “Warrant”), upon the terms and subject to the conditions set forth in such Purchase Agreement. As an inducement to the Initial Purchaser to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Initial Purchaser thereunder, the Company agrees with the Initial Purchaser for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
